MedTrace Logo

Interventions to Help Smoking Parents of Inpatients Reduce Exposure (INSPIRE)

NCT02281864 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2023-01-31

No results posted yet for this study

Summary

Children who are hospitalized are especially vulnerable to the effects of tobacco use and dependence among their caregivers, and they are more likely to be exposed than children who are not hospitalized. Hospitalization is an important teachable moment for health care providers to intervene with tobacco dependent parents, and help them reduce their child's exposure, potentially improving outcomes after hospitalization, and their future health. Understanding the best way to approach and intervene with these families will provide the investigator with the necessary information to create a sustainable intervention that can be disseminated to hospitals across the country that provide pediatric care, and to ultimately make a significant improvement in the health of children.

Conditions

  • Tobacco Use Cessation
  • Second Hand Tobacco Smoke

Interventions

BEHAVIORAL

Smoking Cessation Intervention Bundle

Receipt of the smoke cessation/reduction intervention bundle followed by referral to the Quitline.

OTHER

Control Group: Quitline

Referral to the Quitline

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Karen M Wilson, MD, MPH · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-10
Primary Completion
2019-06-01
Completion
2022-03-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02281864 on ClinicalTrials.gov